Products for Research Use Only
RegisterLogin

JW-65

CAT: 0804-HY-138668-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-138668-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
JW-65 (compound 20) is a TRPC3 inhibitor. JW-65 can be used in neurological and cardiovascular disease related research[1].
CAS Number
2763378-71-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
TRP Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jw-65.html
Purity
99.05
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
FC(C1=C(C(NCC)=O)C=NN1C2=CC=C(C=C2)N(C=CC(Cl)=C3Cl)C3=O)(F)F
Molecular Formula
C18H13Cl2F3N4O2
Molecular Weight
445.22
Precautions
H302, H315, H319
References & Citations
[1]Zhang S, et al. Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity. ACS Med Chem Lett. 2021 Mar 5;12 (4) :572-578.|[2]Nagib MM, et al. Inhibition of TRPC3 channels by a novel pyrazole compound confers antiseizure effects. Epilepsia. 2022 Apr;63 (4) :1003-1015. |[3]Silva-Cardoso GK, et al. Inhibition of TRPC3 channels suppresses seizure susceptibility in the genetically-epilepsy prone rats. Eur J Pharmacol. 2024 Aug 15;977:176722.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
TRPC3

Related Products

CatalogName
HY-13968-01JW 55
HY-12332-01JW 642
HY-117722-01JW 618
HY-12332R-01JW 642 (Standard)
HY-153166-01PT-65
HY-P5746Suicin 65
HY-158697α-Glucosidase-IN-65
HY-164130-01AChE-IN-65
HY-157152HDAC-IN-65
HY-178110HDAC6-IN-65

Alternative Products

CatalogName
T200742-01JW-65
B5556-50JW 480
C3166-25JW 74
A4529-50JW 55
255572-01JW 67
452901-01JW 642
574368JW-67
T84465-01JW 618

Popular Products